The Frequency and Effect of Granulocytic Myeloid-Derived Suppressor Cells on Mycobacterial Survival in Patients With Tuberculosis: A Preliminary Report.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 05 03 2021
accepted: 05 05 2021
entrez: 21 6 2021
pubmed: 22 6 2021
medline: 27 10 2021
Statut: epublish

Résumé

Protective host responses in those exposed to or infected with tuberculosis (TB) is thought to require a delicate balance between pro-inflammatory and regulatory immune responses. Myeloid-derived suppressor cells (MDSCs), regulatory cells that dampen T-cell function, have been described in cancer and other infectious diseases but there are limited data on their role in TB. Peripheral blood was obtained from patients with active pulmonary TB and participants with presumed latent TB infection (LTBI) from Cape Town, South Africa. MDSC frequency was ascertained by flow cytometry. Purified MDSCs were used to assess (i) their suppressive effect on T-cell proliferation using a Ki67 flow cytometric assay and (ii) their effect on mycobacterial containment by co-culturing with H37 MDSCs (CD15 Collectively, these data suggest that circulating MDSCs are induced during active TB disease and can functionally suppress T-cell proliferation and subvert mycobacterial containment. These data may inform the design of vaccines and immunotherapeutic interventions against TB but further studies are required to understand the mechanisms underpinning the effects of MDSCs.

Identifiants

pubmed: 34149712
doi: 10.3389/fimmu.2021.676679
pmc: PMC8207464
doi:

Substances chimiques

CD33 protein, human 0
HLA-DR Antigens 0
Lewis X Antigen 0
Sialic Acid Binding Ig-like Lectin 3 0
Hydrolases EC 3.-
HsaD protein, Mycobacterium tuberculosis EC 3.7.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

676679

Informations de copyright

Copyright © 2021 Davids, Pooran, Smith, Tomasicchio and Dheda.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cells. 2020 Feb 27;9(3):
pubmed: 32121014
Immunol Lett. 2014 Mar-Apr;158(1-2):66-72
pubmed: 24333340
Am J Respir Crit Care Med. 2018 Jul 1;198(1):104-116
pubmed: 29425052
BMJ. 2014 Aug 05;349:g4643
pubmed: 25097193
Am J Respir Crit Care Med. 2014 Nov 1;190(9):1053-66
pubmed: 25275852
J Transl Med. 2011 Jun 09;9:90
pubmed: 21658270
Am J Respir Crit Care Med. 2013 Jun 1;187(11):1249-58
pubmed: 23590266
Eur J Immunol. 2017 Jan;47(1):107-118
pubmed: 27861788
J Infect Dis. 2019 Apr 8;219(8):1329-1337
pubmed: 30452655
Semin Immunol. 2014 Dec;26(6):559-77
pubmed: 25311810
Infect Dis Clin North Am. 2016 Jun;30(2):509-522
pubmed: 27208770
J Immunol. 2010 Feb 15;184(4):2038-47
pubmed: 20083674
Am J Respir Crit Care Med. 2013 Sep 15;188(6):724-32
pubmed: 23885784
JAMA. 1994 Mar 2;271(9):698-702
pubmed: 8309034
Lancet. 2013 Mar 23;381(9871):1021-8
pubmed: 23391465
Eur J Immunol. 2010 Nov;40(11):2969-75
pubmed: 21061430
PLoS One. 2015 Apr 16;10(4):e0123772
pubmed: 25879532
Front Immunol. 2018 Oct 23;9:2417
pubmed: 30405617
N Engl J Med. 2019 Dec 19;381(25):2429-2439
pubmed: 31661198

Auteurs

Malika Davids (M)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.

Anil Pooran (A)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.

Liezel Smith (L)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research; South African Medical Research Council Centre for Tuberculosis Research; Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Michele Tomasicchio (M)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.

Keertan Dheda (K)

Centre for Lung Infection and Immunity, Division of Pulmonology, Department of Medicine and UCT Lung Institute & South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa.
Department of Immunology and Infection, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH